Showing results (981-990 of 1,172) with videos related to
Sort By:
Pageof 118
Stem Cells Translational Medicine|April 16, 2015
Productive Infection of Human Embryonic Stem Cell-Derived NKX2.1+ Respiratory Progenitors with Human RhinovirusRobert A Jenny, Claire Hirst, Sue Mei Lim, et al.British Journal of Haematology|August 8, 2006
Absolute lymphocyte count predicts overall survival in follicular lymphomasMustaqeem Siddiqui, Kay Ristow, Svetomir N Markovic, et al.Bone Marrow Transplantation|December 16, 1998
Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experienceI N Micallef, M Chhanabhai, R D Gascoyne, et al.Therapie|December 19, 2023
What should be done to combat misinformation about health products?Joëlle Micallef, Hervé Maisonneuve, Sophie Muller, et al.Therapie|January 26, 2022
Prevention of risks associated with inappropriate use/unnecessary consumption of medicinesJean-Luc Cracowski, Sophie Muller, Isabelle Anglade, et al.Therapie|March 28, 2017
[Surveillance system on drug abuse: Interest of the French national OPPIDUM program of French addictovigilance network]Elisabeth Frauger, Liselotte Pochard, Quentin Boucherie, et al.JCO Oncology Practice|May 20, 2022
Long-Term Health-Related Quality of Life of Autologous Hematopoietic Cell Transplantation Patients and Nontransplant Patients With Aggressive Lymphoma: A Prospective Cohort AnalysisChristopher S Strouse, Melissa C Larson, Shawna L Ehlers, et al.The International Journal on Drug Policy|August 11, 2015
Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: The LiveRLife StudyA D Marshall, M Micallef, A Erratt, et al.Cancer|October 5, 2017
First-in-human trial of the PI3Kβ-selective inhibitor SAR260301 in patients with advanced solid tumorsPhilippe L Bédard, Michael A Davies, Scott Kopetz, et al.Blood Cancer Journal|April 20, 2013
Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin lymphomaL F Porrata, K M Ristow, T M Habermann, et al.Pageof 118